Cancer stem cells and drug resistance: the potential of nanomedicine - Wikidata - awgldk - TriplyDB

Cancer stem cells and drug resistance: the potential of nanomedicine

Cancer stem cells and drug resistance: the potential of nanomedicine

http://www.wikidata.org/entity/Q26998993

about

Nanotechnology: toxicologic pathology Anti-Cancer Properties of the Naturally Occurring Aphrodisiacs: Icariin and Its Derivatives Cancer of the Pancreas: Molecular Pathways and Current Advancement in Treatment Drug Delivery Using Nanoparticles for Cancer Stem-Like Cell Targeting The Warburg effect and drug resistance Nanomedicine therapeutic approaches to overcome cancer drug resistance Can nanomedicines kill cancer stem cells?Nanomedicine-Mediated Therapies to Target Breast Cancer Stem Cells NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?Cancer chemoprevention with dietary isothiocyanates mature for clinical translational research IMD-0354 targets breast cancer stem cells: a novel approach for an adjuvant to chemotherapy to prevent multidrug resistance in a murine model TRAIL-mediated apoptosis in breast cancer cells cultured as 3D spheroids CD44v6 Monoclonal Antibody-Conjugated Gold Nanostars for Targeted Photoacoustic Imaging and Plasmonic Photothermal Therapy of Gastric Cancer Stem-like Cells.UM-Chor1: establishment and characterization of the first validated clival chordoma cell line.The Dual Roles of MYC in Genomic Instability and Cancer Chemoresistance Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy.Breast cancer as photodynamic therapy target: Enhanced therapeutic efficiency by overview of tumor complexity Multiple drug resistance due to resistance to stem cells and stem cell treatment progress in cancer (Review).Active targeting of mesoporous silica drug carriers enhances γ-secretase inhibitor efficacy in an in vivo model for breast cancer.Targeting specificity of dendritic cells on breast cancer stem cells: in vitro and in vivo evaluations.Getting to the source: selective drug targeting of cancer stem cells.Dendrimer-encapsulated naphthalocyanine as a single agent-based theranostic nanoplatform for near-infrared fluorescence imaging and combinatorial anticancer phototherapy.Differential remodeling of extracellular matrices by breast cancer initiating cells.Galectin-1 is overexpressed in CD133+ human lung adenocarcinoma cells and promotes their growth and invasiveness.Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancer.Biological rationale for the design of polymeric anti-cancer nanomedicines.Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine Mucin 1-mediated chemo-resistance in lung cancer cells.3D-QSAR AND CONTOUR MAP ANALYSIS OF TARIQUIDAR ANALOGUES AS MULTIDRUG RESISTANCE PROTEIN-1 (MRP1) INHIBITORS.Curcumin-encapsulating Nanogels as an Effective Anticancer Formulation for Intracellular Uptake.Comparison of simple models of periodic protocols for combined anticancer therapy Microfluidics 3D gel-island chip for single cell isolation and lineage-dependent drug responses study Overexpression of molecular chaperons GRP78 and GRP94 in CD44(hi)/CD24(lo) breast cancer stem cells.Radio-photothermal therapy mediated by a single compartment nanoplatform depletes tumor initiating cells and reduces lung metastasis in the orthotopic 4T1 breast tumor model.Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells.Targeting Cancer Stem Cells with Nanoparticle-Enabled Therapies.Loss of insulin-like growth factor II imprinting is a hallmark associated with enhanced chemo/radiotherapy resistance in cancer stem cells.Drug-Loaded Polymeric Nanoparticles for Cancer Stem Cell Targeting.Effects of U0126 and MK2206 on cell growth and re-growth of endometriotic stromal cells grown on substrates of varying stiffness

P2860

Q23909945-5CBF2C4F-C601-4AF7-AA87-BD4F4626AEF0 Q26738330-7C08BE0A-1D76-4C8E-A96C-587B3DED3D71 Q26740619-F5ABDB08-BD27-4531-BD5A-F7744D9A0C06 Q26752688-8F1098A8-4310-4E0D-8B92-95C4207D0BE3 Q26770007-C0419295-B412-4283-A8F8-1DB51386B3AD Q27011692-56296ADF-A449-499B-89FC-6A0D20172332 Q27022017-49F69565-41F1-436A-89BB-88CBCC4EF883 Q28066297-04306FBE-0E72-4A4D-AC6B-4C2843A48E8B Q28078448-A4B3927A-4C41-4E6B-B712-4A10C7EBCF10 Q28269727-21C331FA-44AF-4995-8173-EF75C4EBE495 Q28535709-0E1891A3-7EA2-4C3F-B20E-E0198A486F85 Q28544399-CC0F05AC-80AF-43E8-A449-D52D26C37339 Q30407458-C5FAAAC3-F236-483E-B72D-831179C1B7D9 Q33276466-B8B8341C-0F9A-434B-AC7B-10B07DE22853 Q33836799-D1346CB6-8A73-4F09-A26C-3AD088D71F0A Q34448718-F8248C00-3C5A-49F8-BA52-E7A218CE355A Q34657731-936135B5-D849-4AEB-8DAE-BDAFEE0200C9 Q34795591-08F6392A-6C75-4108-92AE-F1C89E9DCC38 Q34881011-F1036101-0BCA-4083-A756-9D13D8671202 Q35063763-797F900F-38D3-4A90-9E45-57D701391F27 Q35156404-A6A45D20-F578-4129-B66A-88850B178449 Q35448036-0471ADCD-5D07-45E1-AE5C-F8A4A02A6D82 Q35544277-6F67ACFB-6063-4043-9A94-7022BB8F69F2 Q35550185-4C5E91BE-272C-42D1-94A7-2FEBCD4AEE25 Q35772708-E04C65E0-068E-4FA7-908B-CDEE159BD401 Q36090771-EBC64BC6-1995-457B-9C2B-11433DB7A201 Q36160333-B6A4B9CF-5924-4C54-86CC-6D7015D2F6FD Q36403289-BDFD1E43-AC0B-4068-B916-82FC6851B75E Q36507586-2A76F84E-6011-48AC-86FF-C111AD07EE9E Q36604036-0E35D6B0-2CAF-4C49-8E53-E6756637C2BE Q36629010-25DBCB33-16A0-42BA-A1BE-6D048455D613 Q36801962-5967CB61-A77E-438B-8315-F66EC287EAFD Q37162664-B6CE6B7A-746A-4A43-BFDC-7DE551EE0102 Q37167969-5399E5CC-481D-43CC-824F-70576BE2405F Q37193545-62E28A9A-3088-4BCE-B0F4-01F05F6393C6 Q37213241-C14DF6E5-DBCD-4412-A4F7-72EF10984B03 Q37419338-26B74AA0-ABCB-43D2-8258-EAEABEEE74FF Q37588289-8A112741-33C1-4764-8F35-D8A873DF5AEA Q37639772-E0D22FB8-9A70-4EBE-B6A8-45451419D576 Q37652650-253AF600-F62B-4424-8C6B-F83E1460E062

P2860

Cancer stem cells and drug resistance: the potential of nanomedicine

http://www.wikidata.org/entity/Q26998993

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Cancer stem cells and drug resistance: the potential of nanomedicine

@ast

Cancer stem cells and drug resistance: the potential of nanomedicine

@en

Cancer stem cells and drug resistance: the potential of nanomedicine

@nl

type

label

Cancer stem cells and drug resistance: the potential of nanomedicine

@ast

Cancer stem cells and drug resistance: the potential of nanomedicine

@en

Cancer stem cells and drug resistance: the potential of nanomedicine

@nl

prefLabel

Cancer stem cells and drug resistance: the potential of nanomedicine

@ast

Cancer stem cells and drug resistance: the potential of nanomedicine

@en

Cancer stem cells and drug resistance: the potential of nanomedicine

@nl

P1433

Q26998993-14A9B8E9-61DD-4ADF-B511-A0421450D6E3

P1476

Q26998993-74A952C8-41A3-41D7-AD66-E966479C19DA

P2093

Q26998993-982FC7E4-0F29-4CF0-BDBD-1DDF18368F7C

Q26998993-D9F3C918-027A-4544-9E1C-7B5E412D2DED

P2860

Q26998993-00263283-6D98-4AF5-8E96-CC65E109DB10

Q26998993-011AC477-D9AF-4AF1-ABCD-DCA81D363BE6

Q26998993-07B5456F-DE2E-4AB2-9A93-CF29E0A3F411

Q26998993-0965A78B-CB6A-41BF-AE45-0CBAC8389D7E

Q26998993-0A170AF6-2B3A-4F86-8410-36CB66390BF9

Q26998993-0C5B38F4-6870-4F83-BD5C-17F5E5906C00

Q26998993-0D6BBEF3-63D4-4E59-8223-51E486C16B7D

Q26998993-158EF324-4280-4A91-88BD-0C7E498C28C0

Q26998993-1804FFE9-D6C4-4B32-86A6-4FE01D3C2DE1

Q26998993-1A5D699F-38C5-4F76-B03B-6B86E88009D7

P304

Q26998993-65524F1A-4899-4AB2-96E1-8CE76D053F69

P31

Q26998993-4C21BBDB-579E-464A-AB38-89F7BA3DD374

P3181

Q26998993-031520DF-F478-4164-B14F-9498A127C778

P356

Q26998993-985798F6-7809-449B-BC8F-343C7EC36750

P407

Q26998993-35708FC6-8671-424D-96B4-B5852EE86377

P433

Q26998993-65EFCDDE-3C1A-43AF-BDEB-B8DA46517F80

P478

Q26998993-01F4F062-CBCE-41E6-9DB8-3409356B561A

P577

Q26998993-DBFEF343-627E-4A7C-AAE1-7C5E1C3570EB

P5875

Q26998993-E369E013-CBCC-4566-92A6-6DA37008E92D

P698

Q26998993-0882464C-FBEA-4BA0-AED5-D0EDB3512D7E

P932

Q26998993-3E3A4B5F-5B34-4DA4-9A14-B206E17AFAB9

P3181

P356

P1433

P1476

Cancer stem cells and drug resistance: the potential of nanomedicine

@en

P2093

Serguei Vinogradov

http://www.w3.org/2001/XMLSchema#string

Xin Wei

http://www.w3.org/2001/XMLSchema#string

P2860

Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer

The stem-cell niche as an entity of action

ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma

Identification of selective inhibitors of cancer stem cells by high-throughput screening

Pulsed ultrasound enhances nanoparticle penetration into breast cancer spheroids.

Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel.

Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling.

P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells.

Hypomethylation-induced expression of S100A4 increases the invasiveness of laryngeal squamous cell carcinoma.

Photothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibody.

P304

597-615

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

432074

http://www.w3.org/2001/XMLSchema#string

P356

10.2217/NNM.12.22

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223984277

http://www.w3.org/2001/XMLSchema#string

P698

22471722

http://www.w3.org/2001/XMLSchema#string

P932

3376090

http://www.w3.org/2001/XMLSchema#string